Reviewed

Pharmaceutical: FENOFIBRATE 145MG (36C77025Q0027)

Waiver type - Procurement: Nonavailability

Agency: VETERANS AFFAIRS, DEPARTMENT OF (3600) • Product Service Code (PSC) : 6505 | Last Modified: 11/08/2024

Procurement Summary

The VA intends to procure the pharmaceutical Fenofibrate. Fenofibrate is used for adjunctive therapy to diet and reduce elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides, and apolipoprotein and to increase high density lipoprotein cholesterol in adult patients with primary hypercholesterolemia or mixed dyslipidemia.

Waiver Rationale Summary

Although the Buy American Act is applicable to small business set-asides (FAR 25.101(b)), the VA will be exercising an exception to the Buy American Act (FAR 25.103(b) Nonavailability) by utilizing a foreign manufacturer, as the anticipated awardee quoted a foreign manufactured end product. No domestic end products were quoted or discovered during market research.

Did / Will the solicitation include one of the standard BAA provisions announcing the agency’s intention to provide a price preference for domestic end products and construction material?

Yes

Was a sources sought or Request for Information issued?

OMB Determination

Consistent with Policy

Product

DRUGS AND BIOLOGICALS

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Date Submitted

10/29/2024

Procurement Instrument Identifier (PIID)

36C77025Q0027

Solicitation ID

36C77025Q0027

Procurement Stage

Post-solicitation

Expected Maximum Duration of the Proposed Waiver

Instant Delivery Only

Waiver Coverage

Individual Waiver

Funding Agency

VETERANS AFFAIRS, DEPARTMENT OF